「全球各團隊表現優異,實現另一季度強勁表現,核心銷售額年增長率達中位數,毛利擴張強勁,現金產生力強勁。這些成果再次證明我們業務的持久性,得益於全球對潔淨水、安全食品和可信賴必需品的需求」,總裁兼首席執行官Jennifer L. Honeycutt表示。「第3季的增長在關鍵終端市場和區域廣泛展開,北美工業水處理需求持續強勁,全球消費品包裝市場逐漸恢復」。
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
Reconciliation of GAAP to Non-GAAP Financial Measures
($ in millions)
Three-Month Period Ended September 27, 2024
Sales
Operating profit
Operating profit margin
Net earnings for calculation of diluted earnings per common share
Diluted net earnings per common share
Reported (GAAP)
$
1,314
$
308
23.4
%
$
219
$
0.88
Amortization of acquisition-related intangible assets A
—
7
0.5
%
7
0.03
Loss on disposition of certain product lines B
—
—
—
(5)
(0.02)
Other items C
—
2
0.2
%
2
0.01
Tax effect of the above adjustments F
—
—
—
(1)
—
Discrete tax adjustments G
—
—
—
1
—
Rounding
—
—
—
—
(0.01)
Adjusted (Non-GAAP)
$
1,314
$
317
24.1
%
$
223
$
0.89
Three-Month Period Ended September 29, 2023
Sales
Operating profit
Operating profit margin
Net earnings for calculation of diluted earnings per common share
Diluted net earnings per common share
Reported (GAAP)
$
1,255
$
273
21.8
%
$
205
$
0.83
Amortization of acquisition-related intangible assets A
—
12
1.0
12
0.05
Impairments and other charges D
—
6
0.5
6
0.02
Standalone Adjustment E
2
(10)
(0.8)
(40)
(0.16)
Tax effect of the above adjustments F
—
—
—
7
0.03
Discrete tax adjustments G
—
—
—
(6)
(0.02)
Rounding
—
—
(0.1)
—
—
Adjusted (Non-GAAP)
$
1,257
$
281
22.4
%
$
184
$
0.75
4
VERALTO CORPORATION
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
Notes to Reconciliation of GAAP to Non-GAAP Financial Measures
($ in millions)
A Amortization of acquisition-related intangible assets in the following historical periods (only the pretax amounts set forth below are reflected in the amortization line item above):
Three-Month Period Ended
September 27, 2024
September 29, 2023
Pretax
$
7
$
12
After-tax
5
9
B Gain on the disposition of a certain product line in the three-month period ended September 29, 2023 ($5 million gain pretax as reported in this line item, $4 million gain after-tax).
C Costs incurred in the three-month period ended September 27, 2024 related to certain strategic initiatives ($2 million pretax and after-tax as reported in this line item).
D Impairment charge related to tradenames in the Product Quality & Innovation segment for the three-month period ended September 29, 2023 totaling $6 million, as reported in this line item, and $5 million after-tax.
E This amount encompasses management estimates of operating as a standalone entity. The management estimate includes recurring and ongoing costs required to operate new functions required for a public company such as certain corporate functions including finance, tax, legal, human resources and other general and administrative related functions. The pre-tax and after-tax effect of these estimates are summarized below:
Three-Month Period Ended
September 29, 2023
Impact to Operating Profit
$
(10)
Pretax
(40)
After-tax
(29)
F This line item reflects the aggregate tax effect of all nontax adjustments reflected in the preceding line items of the table. In addition, the footnotes above indicate the after-tax amount of each individual adjustment item. Veralto estimates the tax effect of each adjustment item by applying Veralto’s overall estimated effective tax rate to the pretax amount, unless the nature of the item and/or the tax jurisdiction in which the item has been recorded requires application of a specific tax rate or tax treatment, in which case the tax effect of such item is estimated by applying such specific tax rate or tax treatment.
G Discrete tax matters relate to changes in estimates associated with prior period uncertain tax positions, audit settlements and excess tax benefits from stock-based compensation.
5
VERALTO CORPORATION
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
Sales Growth by Segment, Core Sales Growth by Segment
% Change Three-Month Period Ended September 27, 2024 vs. Comparable 2023 Period
Segments
Total Company
Water Quality
Product Quality and Innovation
Total sales growth (GAAP)
4.7
%
3.6
%
6.3
%
Impact of:
Acquisitions/divestitures
—
%
0.2
%
(0.2)
%
Currency exchange rates
(0.1)
%
0.2
%
(0.4)
%
Core sales growth (non-GAAP)
4.6
%
4.0
%
5.7
%
6
VERALTO CORPORATION
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
Forecasted Core Sales Growth, Adjusted Operating Profit Margin, and Adjusted Diluted Net Earnings per Share
The Company provides forecasted sales only on a non-GAAP basis because of the difficulty in estimating the other components of GAAP revenue, such as currency translation, acquisitions and divested product lines. Additionally, we do not reconcile adjusted operating profit margin (or components thereof), adjusted diluted earnings per share or free cash flow to net earnings conversion ratio to the comparable GAAP measures because of the difficulty in estimating the other unknown components such as investment gains and losses, impairments and separation costs, which would be reflected in any forecasted GAAP operating profit, forecasted diluted earnings per share or forecasted net earnings ratio.
% Change Three-Month Period Ending December 31, 2024 vs. Comparable 2023 Period
Core sales growth (non-GAAP)
+Low-single digit to +Mid-single digit
Three-Month Period Ending December 31, 2024
Adjusted Operating Profit Margin (non-GAAP)
~24.0%
Adjusted Diluted Net Earnings per Share (non-GAAP)
$0.86 to $0.90
% Change Year Ending December 31, 2024 vs. Comparable 2023 Period
Core sales growth (non-GAAP)
+Low-single digits
Year Ending December 31, 2024
Adjusted Operating Profit Margin (non-GAAP)
~75 basis points
Adjusted Diluted Net Earnings per Share (non-GAAP)
$3.44 to $3.48
Free cash flow to net earnings conversion ratio (non-GAAP)
100% to 110%
7
VERALTO CORPORATION
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
Cash Flow and Free Cash Flow
($ in millions)
Three-Month Period Ended
Year-over-Year Change
September 27, 2024
September 29, 2023
Total Cash Flows:
Net cash provided by operating activities (GAAP)
$
224
$
243
Total cash used in investing activities (GAAP)
$
(6)
$
(14)
Total cash provided by (used in) financing activities (GAAP)
$
(16)
$
206
Free Cash Flow:
Total cash provided by operating activities (GAAP)
$
224
$
243
~ (8.0)
%
Less: payments for additions to property, plant & equipment (capital expenditures) (GAAP)
(9)
(11)
Plus: proceeds from sales of property, plant & equipment (capital disposals) (GAAP)
—
—
Free cash flow (non-GAAP)
$
215
$
232
~ (7.5)
%
We define free cash flow as operating cash flows, less payments for additions to property, plant and equipment (“capital expenditures”) plus the proceeds from sales of plant, property and equipment (“capital disposals”).
8
Statement Regarding Non-GAAP Measures
Each of the non-GAAP measures set forth above should be considered in addition to, and not as a replacement for or superior to, the comparable GAAP measure, and may not be comparable to similarly titled measures reported by other companies. Management believes that these measures provide useful information to investors by offering additional ways of viewing Veralto Corporation’s (“Veralto” or the “Company”) results that, when reconciled to the corresponding GAAP measure, help our investors:
•with respect to the profitability-related non-GAAP measures, understand the long-term profitability trends of our business and compare our profitability to prior and future periods and to our peers;
•with respect to core sales and related sales measures, identify underlying growth trends in our business and compare our sales performance with prior and future periods and to our peers; and
•with respect to free cash flow and related cash flow measures (the “FCF Measure”), understand Veralto’s ability to generate cash without external financings, strengthen its balance sheet, invest in its business and grow its business through acquisitions and other strategic opportunities (although a limitation of free cash flow is that it does not take into account the Company’s non-discretionary expenditures, and as a result the entire free cash flow amount is not necessarily available for discretionary expenditures).
Management uses these non-GAAP measures to measure the Company’s operating and financial performance.
•The items excluded from the non-GAAP measures set forth above have been excluded for the following reasons:
◦Amortization of Intangible Assets: We exclude the amortization of acquisition-related intangible assets because the amount and timing of such charges are significantly impacted by the timing, size, number and nature of the acquisitions we consummate. While we have a history of significant acquisition activity, we do not acquire businesses on a predictable cycle, and the amount of an acquisition’s purchase price allocated to intangible assets and related amortization term are unique to each acquisition and can vary significantly from acquisition to acquisition. Exclusion of this amortization expense facilitates more consistent comparisons of operating results over time between our newly acquired and long-held businesses, and with both acquisitive and non-acquisitive peer companies. We believe however that it is important for investors to understand that such intangible assets contribute to sales generation and that intangible asset amortization related to past acquisitions will recur in future periods until such intangible assets have been fully amortized.
◦Restructuring Charges: We exclude costs incurred pursuant to discrete restructuring plans that are fundamentally different (in terms of the size, strategic nature and planning requirements, as well as the inconsistent frequency, of such plans) from the ongoing productivity improvements that result from application of the Veralto Enterprise System. Because these restructuring plans are incremental to the core activities that arise in the ordinary course of our business and we believe are not indicative of Veralto’s ongoing operating costs in a given period, we exclude these costs to facilitate a more consistent comparison of operating results over time.
◦Other Adjustments: With respect to the other items excluded from the profitability-related non-GAAP measures, we exclude these items because they are of a nature and/or size that occur with inconsistent frequency, occur for reasons that may be unrelated to Veralto’s commercial performance during the period and/or we believe that such items may obscure underlying business trends and make comparisons of long-term performance difficult.
◦Standalone Adjustments: We believe these adjustments provide additional insight into how our businesses are performing, on a normalized basis. However, these non-GAAP financial measures should not be construed as inferring that our future results will be unaffected by the items for which the measure adjusts.
•With respect to core operating profit margin changes, in addition to the explanation set forth in the bullets above relating to “restructuring charges” and “other adjustments”, we exclude the impact of businesses owned for less than one year (or disposed of during such period and not treated as discontinued operations) because the timing, size, number and nature of such transactions can vary significantly from period to period and may obscure underlying business trends and make comparisons of long-term performance difficult.
•With respect to core sales related measures, (1) we exclude the impact of currency translation because it is not under management’s control, is subject to volatility and can obscure underlying business trends, and (2) we exclude the effect of acquisitions and divested product lines because the timing, size, number and nature of such transactions can vary significantly from period-to-period and between us and our peers, which we believe may obscure underlying business trends and make comparisons of long-term performance difficult.
•With respect to the FCF Measure, we exclude payments for additions to property, plant and equipment (net of the proceeds from capital disposals) to demonstrate the amount of operating cash flow for the period that remains after accounting for the Company’s capital expenditure requirements.